Nivalis Therapeutics, Inc. (ALPN)
(Delayed Data from NSDQ)
$6.24 USD
-0.08 (-1.27%)
Updated May 3, 2019 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
[ALPN]
Reports for Purchase
Showing records 121 - 140 ( 156 total )
Industry: Medical - Drugs
Preclinical AACR II Update: ALPN-202 MOA Extends to Macrophages
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Industry: Medical - Drugs
Industry: Medical - Drugs
AbbVie Partnership Directs ALPN-101 to Lupus; Raising PT to $22
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Industry: Medical - Drugs
EULAR 2020 Takeaways: ALPN-101 HV Update and New B Cell Preclinical Programs
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Industry: Medical - Drugs
Q1 Financials; First Patient Dosed in BALANCE Acute GvHD Study
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Industry: Medical - Drugs
Industry: Medical - Drugs
CORRECTED AACR 2020 Titles for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Q4 Financials; BALANCE and NEON-1 Studies Now Open for Enrollment
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Industry: Medical - Drugs
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
ALPN-101 Healthy Volunteer Safety Looks Clean; BALANCE Study Details Announced
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Q3 Financials; ALPN-101 Data Presentation at ASH Ahead
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Industry: Medical - Drugs
Industry: Medical - Drugs
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Biotechnology - SITC 2019 Abstract Title Preview for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Industry: Medical - Drugs
Q2 Financials; IND for ALPN-202 on Track for 2H:19
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Industry: Medical - Drugs
Industry: Medical - Drugs
2019 PacGrow Healthcare Conference: Day 1 Recap
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Industry: Medical - Drugs
Adaptimmune taps Alpine Immune for 2nd Gen. TCR Therapies
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R